With the undisputed passage of the Virginia bill, loopholes have been cleared for legal production and distribution of marijuana oils. Epileptics may have to wait for 2017. After many arguments rolled, Bill SB701came through. The bill stipulates terms for the production of Cannabidiol and THCA oils. Both these marijuana oils have low THC levels. THC promotes the high in marijuana.
Senator Dave Marsden backed the legislation and said that the oils would alleviate chronic epileptic conditions and reduce the number of seizures. Families could look forward to a better quality of life. The Senator hailed the bill as a great step for Virginia that shows the way by providing safe and secure medication. The bill now waits for the Governor’s signature.
Though the two oils were sanctioned legally for severe epilepsy, there existed no legal method to obtain the oils for treatment. Patients would have had to break Federal and state laws in acquiring them. Now, according to SB701, the Board of Pharmacy would set up guidelines to supply the oils legally. The guidelines need the approval of the legislature before coming into effect. The processed oils would be distributed during 2017.
Cannabis has had its ups and downs, sometimes called a villain and divine grace at other times. As many as 40 American states, including Virginia, now observe medical marijuana laws. Americans for Safe Access has prepared a report indicating that 17 states including Virginia restrict cannabis preparations to the use of THCA and CBD oils. Patients do not need the high. ASA holds its fourth Annual Medical Cannabis Unity Conference soon in Washington.
The march of legal history could not have been more dramatic. Children certainly have a right to avail of medical marijuana that now seems to be the ultimate solution to alleviate serious epilepsy but laws did not allow it earlier. The medical cannabis dream is soon coming true. Heart-rending cases of daily seizures and the inability to walk have plagued numerous kids.
Special diets and about 18 kinds of medications resulted in terrible side effects. In spite of medical cannabis laws in 23 states, the curse of the Federal Schedule 1 drug classification yet remains. The classification implies no accepted medical usage and great potential for abuse. Besides, restrictions on cannabis research delayed legal implementation for years. H.R.1635 and S.1333 in the US Congress may remove that burden of a cursed classification.
